Icagen, Inc. to Present at the Antiepileptic Drug Trials XI Conference

RESEARCH TRIANGLE PARK, N.C., April 19, 2011 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that management will participate in the Antiepileptic Drug Trials XI Conference to be held April 27 through April 29, 2011 at the Turnberry Isle Resort in Aventura, Florida. Greg C. Rigdon, Ph.D., Vice President, New Product Development, will summarize recent clinical study results and plans for next steps in the development of ICA-105665 at 11:30 a.m. Eastern Time on Friday, April 29, 2011.